FR2390959A1 - Association therapeutique a visee anti-agregante et regularisatrice de la duree de vie plaquettaire a base de pyrimido-pyrimidine et d'acide acetyl salycilique - Google Patents

Association therapeutique a visee anti-agregante et regularisatrice de la duree de vie plaquettaire a base de pyrimido-pyrimidine et d'acide acetyl salycilique

Info

Publication number
FR2390959A1
FR2390959A1 FR7814338A FR7814338A FR2390959A1 FR 2390959 A1 FR2390959 A1 FR 2390959A1 FR 7814338 A FR7814338 A FR 7814338A FR 7814338 A FR7814338 A FR 7814338A FR 2390959 A1 FR2390959 A1 FR 2390959A1
Authority
FR
France
Prior art keywords
compsns
useful
pyrimido
aspirin
pyrimidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7814338A
Other languages
English (en)
French (fr)
Other versions
FR2390959B1 (de
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PRUGNAUD ROBERT
Original Assignee
PRUGNAUD ROBERT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PRUGNAUD ROBERT filed Critical PRUGNAUD ROBERT
Publication of FR2390959A1 publication Critical patent/FR2390959A1/fr
Application granted granted Critical
Publication of FR2390959B1 publication Critical patent/FR2390959B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7814338A 1977-05-16 1978-05-12 Association therapeutique a visee anti-agregante et regularisatrice de la duree de vie plaquettaire a base de pyrimido-pyrimidine et d'acide acetyl salycilique Granted FR2390959A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU77353A LU77353A1 (de) 1977-05-16 1977-05-16

Publications (2)

Publication Number Publication Date
FR2390959A1 true FR2390959A1 (fr) 1978-12-15
FR2390959B1 FR2390959B1 (de) 1983-03-25

Family

ID=19728580

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7814338A Granted FR2390959A1 (fr) 1977-05-16 1978-05-12 Association therapeutique a visee anti-agregante et regularisatrice de la duree de vie plaquettaire a base de pyrimido-pyrimidine et d'acide acetyl salycilique

Country Status (2)

Country Link
FR (1) FR2390959A1 (de)
LU (1) LU77353A1 (de)

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2452923A2 (fr) * 1979-04-02 1980-10-31 Panoz Donald Nouvelle forme galenique d'administration de medicaments par voie orale, a liberation programmee
FR2452922A2 (fr) * 1979-04-02 1980-10-31 Panoz Donald Nouvelle forme galenique d'administration de medicaments par voie orale, a liberation programmee
FR2453642A1 (fr) * 1979-04-12 1980-11-07 Sanofi Sa Compositions therapeutiques a usage oral et a liberation programmee du methanesulfonate de dihydroergotoxine
FR2454804A1 (fr) * 1979-04-26 1980-11-21 Sanofi Sa Medicament a base de dihydroergotoxine et son procede de preparation
FR2470599A1 (fr) * 1979-12-07 1981-06-12 Panoz Donald Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
FR2470600A2 (fr) * 1979-12-07 1981-06-12 Panoz Donald Nouvelle forme galenique d'administration de medicaments par voie orale, a liberation programmee
EP0032562A1 (de) * 1980-01-12 1981-07-29 Dr. Karl Thomae GmbH Neue Dipyridamol-Retardformen und Verfahren zu ihrer Herstellung
WO1982001468A1 (en) * 1980-10-28 1982-05-13 Claude Laruelle New galenical administration form of metoclopramide,method for its preparation and medicament comprising this new form
EP0052075A1 (de) * 1980-11-12 1982-05-19 Ciba-Geigy Ag Körnige Arzneimittel-Retardform
FR2494112A1 (de) * 1980-11-19 1982-05-21 Laruelle Claude
EP0068191A2 (de) * 1981-06-19 1983-01-05 Dr. Karl Thomae GmbH Orale Dipyridamolformen
FR2513118A1 (fr) * 1981-09-18 1983-03-25 Rocador Sa Composition pharmaceutique a base de dipyridamol et de sel d'aluminium de l'acide acetylsalicylique pour combattre l'agregation plaquettaire
US4444777A (en) * 1981-07-30 1984-04-24 Bristol-Myers Company Pharmaceutical compositions of anagrelide and sulfinpyrazone
FR2539995A1 (fr) * 1983-01-28 1984-08-03 Sanofi Sa Medicament a liberation programmee a base d'acide acetylsalicylique
EP0169465A2 (de) * 1984-07-21 1986-01-29 Hoechst Aktiengesellschaft Kombinationspräparat aus Pyrimido-pyrimidinen und O-Acetylsalicylsäure bzw. deren pharmakologisch verträglichen Salzen und dessen Verwendung
US4609542A (en) * 1978-12-22 1986-09-02 Elan Corporation, P.L.C. New pharmaceutical forms for administration of medicaments by oral route, with programmed release
EP0257344A1 (de) * 1986-08-13 1988-03-02 Dr. Karl Thomae GmbH Arzneimittel enthaltend Dipyridamol oder Mopidamol und O-Acetylsalicylsäure bzw. deren physiologisch verträgliche Salze, Verfahren zu ihrer Herstellung und ihre Verwendung zur Bekämpfung der Thrombusbildung
WO1991004031A1 (en) * 1989-09-18 1991-04-04 The Du Pont Merck Pharmaceutical Company Oral anticoagulant/platelet inhibitor low dose formulation
AT393962B (de) * 1987-10-22 1992-01-10 Thomae Gmbh Dr K Synergistische arzneimittelkombination mit einem gehalt an einem phosphodiesterase-hemmer und derenverwendung
FR2681596A1 (fr) * 1991-09-23 1993-03-26 Thomas Andre Procede de preparation d'acetylsalicylates des bases puriques et pyrimidiques et de leurs nucleosides.
WO2010036975A2 (en) * 2008-09-25 2010-04-01 Teva Pharmaceutical Industries Ltd. Dipyridamole and acetylsalicylic acid formulations and process for preparing same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NV2030/77 *

Cited By (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4609542A (en) * 1978-12-22 1986-09-02 Elan Corporation, P.L.C. New pharmaceutical forms for administration of medicaments by oral route, with programmed release
US4726951A (en) * 1978-12-22 1988-02-23 Elan Corporation P.L.C. New pharmaceutical forms for administration of medicaments by oral route, with programmed release
FR2452922A2 (fr) * 1979-04-02 1980-10-31 Panoz Donald Nouvelle forme galenique d'administration de medicaments par voie orale, a liberation programmee
FR2452923A2 (fr) * 1979-04-02 1980-10-31 Panoz Donald Nouvelle forme galenique d'administration de medicaments par voie orale, a liberation programmee
FR2453642A1 (fr) * 1979-04-12 1980-11-07 Sanofi Sa Compositions therapeutiques a usage oral et a liberation programmee du methanesulfonate de dihydroergotoxine
FR2454804A1 (fr) * 1979-04-26 1980-11-21 Sanofi Sa Medicament a base de dihydroergotoxine et son procede de preparation
US5051262A (en) * 1979-12-07 1991-09-24 Elan Corp., P.L.C. Processes for the preparation of delayed action and programmed release pharmaceutical forms and medicaments obtained thereby
FR2470599A1 (fr) * 1979-12-07 1981-06-12 Panoz Donald Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
FR2470600A2 (fr) * 1979-12-07 1981-06-12 Panoz Donald Nouvelle forme galenique d'administration de medicaments par voie orale, a liberation programmee
WO1981001652A1 (fr) * 1979-12-07 1981-06-25 D Panoz Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenues
EP0032562B1 (de) * 1980-01-12 1984-03-14 Dr. Karl Thomae GmbH Neue Dipyridamol-Retardformen und Verfahren zu ihrer Herstellung
EP0032562A1 (de) * 1980-01-12 1981-07-29 Dr. Karl Thomae GmbH Neue Dipyridamol-Retardformen und Verfahren zu ihrer Herstellung
US4367217A (en) 1980-01-12 1983-01-04 Boehringer Ingelheim Gmbh Dipyricamole sustained release forms comprising lacquer-coated particles and the preparation thereof
WO1982001468A1 (en) * 1980-10-28 1982-05-13 Claude Laruelle New galenical administration form of metoclopramide,method for its preparation and medicament comprising this new form
JPS57502121A (de) * 1980-10-28 1982-12-02
EP0052075A1 (de) * 1980-11-12 1982-05-19 Ciba-Geigy Ag Körnige Arzneimittel-Retardform
FR2494112A1 (de) * 1980-11-19 1982-05-21 Laruelle Claude
DE3152519C2 (de) * 1980-11-19 1990-11-22 Claude Laruelle Neues Fenofibrat-Fertigpr{parat mit verz¦gerter Wirkstofffreisetzung
WO1982001649A1 (fr) * 1980-11-19 1982-05-27 Laruelle Claude Nouvelle forme galenique du fenofibrate, son procede d'obtention, son application comme medicament
EP0068191A3 (en) * 1981-06-19 1983-08-10 Dr. Karl Thomae Gmbh Oral forms of dipyridamole
EP0068191A2 (de) * 1981-06-19 1983-01-05 Dr. Karl Thomae GmbH Orale Dipyridamolformen
US4444777A (en) * 1981-07-30 1984-04-24 Bristol-Myers Company Pharmaceutical compositions of anagrelide and sulfinpyrazone
FR2513118A1 (fr) * 1981-09-18 1983-03-25 Rocador Sa Composition pharmaceutique a base de dipyridamol et de sel d'aluminium de l'acide acetylsalicylique pour combattre l'agregation plaquettaire
EP0115976A1 (de) * 1983-01-28 1984-08-15 Elf Sanofi Arzneimittel mit programmierter Abgabe Acetylsalicylsäure enthaltend
FR2539995A1 (fr) * 1983-01-28 1984-08-03 Sanofi Sa Medicament a liberation programmee a base d'acide acetylsalicylique
EP0169465A2 (de) * 1984-07-21 1986-01-29 Hoechst Aktiengesellschaft Kombinationspräparat aus Pyrimido-pyrimidinen und O-Acetylsalicylsäure bzw. deren pharmakologisch verträglichen Salzen und dessen Verwendung
EP0169465A3 (en) * 1984-07-21 1986-05-28 Hoechst Aktiengesellschaft Mixture of pyrimido-pyrimidines and o-acetyl-salicylic acid, or their pharmacologically acceptable salts, and its use
EP0257344A1 (de) * 1986-08-13 1988-03-02 Dr. Karl Thomae GmbH Arzneimittel enthaltend Dipyridamol oder Mopidamol und O-Acetylsalicylsäure bzw. deren physiologisch verträgliche Salze, Verfahren zu ihrer Herstellung und ihre Verwendung zur Bekämpfung der Thrombusbildung
US6015577A (en) * 1986-08-13 2000-01-18 Dr. Karl Thomae GmbH Pharmaceutical compositions containing dipyridamole or mopidamol and acetylsalicylic acid or the physiologically acceptable salts thereof, processes for preparing them and their use in treating clot formation
AT393962B (de) * 1987-10-22 1992-01-10 Thomae Gmbh Dr K Synergistische arzneimittelkombination mit einem gehalt an einem phosphodiesterase-hemmer und derenverwendung
US5041430A (en) * 1989-09-18 1991-08-20 Du Pont Mereck Pharmaceutical Company Oral anticoagulant/platelet inhibitor low dose formulation
GR900100702A (en) * 1989-09-18 1992-01-20 Du Pont Low dosage oral antithrombotic composition
WO1991004031A1 (en) * 1989-09-18 1991-04-04 The Du Pont Merck Pharmaceutical Company Oral anticoagulant/platelet inhibitor low dose formulation
FR2681596A1 (fr) * 1991-09-23 1993-03-26 Thomas Andre Procede de preparation d'acetylsalicylates des bases puriques et pyrimidiques et de leurs nucleosides.
WO2010036975A2 (en) * 2008-09-25 2010-04-01 Teva Pharmaceutical Industries Ltd. Dipyridamole and acetylsalicylic acid formulations and process for preparing same
WO2010036975A3 (en) * 2008-09-25 2010-08-12 Teva Pharmaceutical Industries Ltd. Dipyridamole and acetylsalicylic acid formulations and process for preparing same

Also Published As

Publication number Publication date
FR2390959B1 (de) 1983-03-25
LU77353A1 (de) 1979-01-19

Similar Documents

Publication Publication Date Title
FR2390959A1 (fr) Association therapeutique a visee anti-agregante et regularisatrice de la duree de vie plaquettaire a base de pyrimido-pyrimidine et d'acide acetyl salycilique
FR2329261A1 (fr) Corps d'insertion oculaire pour le traitement de la siccite oculaire par deficience aqueuse
AR248140A1 (es) Composicion de 1, 4, 7, 10-tetraazaciclododecano como la fraccion macrolitica, o sales fisiologicamente aceptables del mismo y radionuclidos como agente terapeuticamente activo.
IE870194L (en) Use of lithium compounds in senile dementia
EP0259485A4 (de) Schwermetallsalze von hyaluronsäure zur verwendung als antimikrobielles mittel.
EP0285008A3 (en) The use of buspirone for preparing a pharmaceutical composition for the treatment of alcohol abuse
ATE103812T1 (de) Zusammensetzung zur behandlung von ischaemischen stoerungen in organen.
DK154208C (da) Analogifremgangsmaade til fremstilling af p-substituerede 3-fenoxy-1-alkylaminopropanoler eller terapeutisk acceptable salte deraf
DK644388A (da) Farmaceutiske praeparater indeholdende 3-hydroxy-smoeresyrederivater
ATE109350T1 (de) Verwendung von ofloxacin oder dessen salzen zur herstellung eines lokalpräparats für die behandlung von otopathie.
ATE84716T1 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelialgewebekrankheiten.
FI91876B (fi) Menetelmä nootrooppisen vaikutuksen omaavien aminohappojohdannaisten valmistamiseksi
IT8721115A0 (it) Fitopreparato per la cura di affezioni cutanee.
HUT51295A (en) Process for producing peptidalcohol derivatives of anticoagulant activity
MY104521A (en) Treatment of depression.
ATE206053T1 (de) Verwendung von monosialogangliosid gml oder von n-dichlor-acetyl-lyso-gml zur vorbeugung oder zur umkehrung der von einer langzeitbehandlung mit l- dopa bei der therapie von morbus parkinson induzierten neuronale degeneration
ES2036533T3 (es) Derivados de 1,6-naftiridina, procedimientos para su obtencion y de medicamentos que los contienen para el tratamiento de enfermedades de los vasos sanguineos.
PT85866A (en) Process for the preparation of therapeutic agents for the treatment of peptic ulcers containing 1,2,3,6-tetrahydro-3-methyl-1-(5-oxohexyl)-7-propyl-purine,6-dione and their derivatives
ZA814902B (en) Novel thiazol-2-yl-oxamic acid derivatives,their preparation and therapeutic agents containing these compounds
FR2622443B1 (fr) Agent contenant un compose organogermanium pour ameliorer les fonctions des organes reduites par une inhibition de la circulation du sang
ATE49958T1 (de) Pharmazeutische zusammensetzungen mit immunodepressivwirkung.
DE3168004D1 (en) Ophthalmic composition of 5-fluoro-2-methyl-1-(p-methylthio-benzylidene)-3-indenylacetic acid or salt thereof
ZA897549B (en) Medicament for the treatment of diseases caused by retroviruses
NZ182524A (en) Synergistic combinations of 2-(4,5-bis-p-chlorophenyloxazol-2-ylmercapto)-propionic acid, or salts there of,and acetyl-salicylic acid,or a salt there of
NL7501793A (en) Beta-adrenolytic 2-hydroxy 3-alkyl amino propanes - contg. 1-(amino-phenoxy) gp, prepd. e.g. from epoxy cpd. and amine

Legal Events

Date Code Title Description
ST Notification of lapse